UGI Corporation (UGI)

Blueprint Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	7,546	5,372	4,818	6,769	8,912	6,870
Market Cap Growth	62.70%	11.49%	-28.83%	-24.04%	29.71%	-34.59%
Enterprise Value	14,150	12,119	11,850	12,992	14,643	13,206
PE Ratio	18.33	19.97	-	6.31	6.08	12.91
PS Ratio	1.03	0.75	0.54	0.67	1.20	1.05
PB Ratio	1.55	1.23	1.10	1.11	1.61	1.66
P/FCF Ratio	17.03	13.92	36.23	-	11.27	15.37
P/OCF Ratio	5.86	4.54	4.35	9.45	6.02	6.24
EV/Sales Ratio	1.93	1.68	1.33	1.29	1.97	2.01
EV/EBITDA Ratio	8.80	7.39	-	5.94	4.97	8.37
EV/EBIT Ratio	13.41	11.12	-	7.79	6.00	12.08
EV/FCF Ratio	31.94	31.40	89.10	-	18.51	29.54
Debt / Equity Ratio	1.42	1.74	1.75	1.21	1.30	1.64
Debt / EBITDA Ratio	4.02	4.29	264.69	3.22	2.36	4.03
Debt / FCF Ratio	15.70	19.62	57.71	-	9.12	15.22
Quick Ratio	0.49	0.49	0.52	0.69	0.82	0.62
Current Ratio	0.71	0.80	0.90	1.56	1.42	0.88
Asset Turnover	0.48	0.47	0.54	0.59	0.49	0.48
Return on Equity (ROE)	8.73%	6.15%	-28.70%	18.51%	30.35%	13.36%
Return on Assets (ROA)	4.33%	4.47%	-2.32%	6.08%	9.94%	5.00%
Return on Capital (ROIC)	5.62%	5.68%	-3.00%	7.96%	12.89%	6.40%
Return on Capital Employed (ROCE)	8.20%	8.40%	-	11.00%	16.90%	8.90%
Earnings Yield	5.54%	5.01%	-31.18%	15.85%	16.46%	7.74%
Earnings Yield	5.54%	5.01%	-31.18%	15.85%	16.46%	7.74%
FCF Yield	5.87%	7.19%	2.76%	-1.30%	8.88%	6.51%
Dividend Yield	4.27%	6.21%	7.05%	5.05%	3.81%	4.93%
Payout Ratio	78.31%	118.22%	-	27.59%	19.22%	51.32%
Buyback Yield / Dilution	-1.78%	-2.60%	2.79%	-1.74%	-1.07%	-15.88%
Total Shareholder Return	2.49%	3.60%	9.84%	3.31%	2.73%	-10.95%

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.

SEC Filings: 10-K · 10-Q